Conyers Park III Acquisition, the third blank check company led by consumer industry veterans from Centerview Capital, raised $350 million by offering 35 million units at $10. Each unit consists of one share of common stock and one-third of a warrant exercisable at $11.50 per share. The company is led by three partners at the SPAC's sponsor, Centerview Capital: ...read more
After a record breaking number of deals last week, the IPO market cooled off for the shortened holiday week, with just two micro-cap IPOs raising $45 million. Preclinical RNA biotech Transcode Therapeutics (RNAZ) priced at $4 to raise $25 million at a $54 million market cap. This oncology biotech develops RNA therapeutics for the treatment of solid...read more
Conyers Park III Acquisition, the third blank check company led by consumer industry veterans from Centerview Capital, filed on Tuesday with the SEC to raise up to $350 million in an initial public offering. The Naples, FL-based company plans to raise $350 million by offering 35 million units at a price of $10. There it would command a market value of $438 million. Each unit...read more
Nine companies entered the public market this week, led by customer experience software provider Medallia (MDLA) with a first day pop of 76%. The software company priced at $21, well above the range, to raise $326 million at a fully diluted valuation of $3.6 billion. Medallia’s growth accelerated to 32% in the most recent quarter, and it boasts 32...read more
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Centerview consumer SPAC Conyers Park III Acquisition prices $350 million IPO
Conyers Park III Acquisition, the third blank check company led by consumer industry veterans from Centerview Capital, raised $350 million by offering 35 million units at $10. Each unit consists of one share of common stock and one-third of a warrant exercisable at $11.50 per share. The company is led by three partners at the SPAC's sponsor, Centerview Capital: ...read more
US IPO Weekly Recap: Micro-caps lead a quiet 2 IPO week
After a record breaking number of deals last week, the IPO market cooled off for the shortened holiday week, with just two micro-cap IPOs raising $45 million. Preclinical RNA biotech Transcode Therapeutics (RNAZ) priced at $4 to raise $25 million at a $54 million market cap. This oncology biotech develops RNA therapeutics for the treatment of solid...read more
Centerview consumer SPAC Conyers Park III Acquisition files for a $350 million IPO
Conyers Park III Acquisition, the third blank check company led by consumer industry veterans from Centerview Capital, filed on Tuesday with the SEC to raise up to $350 million in an initial public offering. The Naples, FL-based company plans to raise $350 million by offering 35 million units at a price of $10. There it would command a market value of $438 million. Each unit...read more
US IPO Weekly Recap: Medallia tops a 9-IPO week with a 76% first day return
Nine companies entered the public market this week, led by customer experience software provider Medallia (MDLA) with a first day pop of 76%. The software company priced at $21, well above the range, to raise $326 million at a fully diluted valuation of $3.6 billion. Medallia’s growth accelerated to 32% in the most recent quarter, and it boasts 32...read more